Development of a proteomic signature associated with severe disease for patients with COVID-19 using data from 5 multicenter, randomized, controlled, and prospective studies.

Of note, CK-MB and CK-MM are located at the upper left quadrant, suggesting a highly significant p-value and relatively large log fold change, and lower levels of CK-MB and CK-MM in the moderate/severe group over 15 days.

also in 132,142 other papers